Logo image of CCL-B.CA

CCL INDUSTRIES INC - CL B (CCL-B.CA) Stock Fundamental Analysis

TSX:CCL-B - Toronto Stock Exchange - CA1249003098 - Common Stock - Currency: CAD

78.15  +0.13 (+0.17%)

Fundamental Rating

6

Overall CCL-B gets a fundamental rating of 6 out of 10. We evaluated CCL-B against 8 industry peers in the Containers & Packaging industry. While CCL-B belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. CCL-B is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

CCL-B had positive earnings in the past year.
CCL-B had a positive operating cash flow in the past year.
Each year in the past 5 years CCL-B has been profitable.
Each year in the past 5 years CCL-B had a positive operating cash flow.
CCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCCL-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

CCL-B has a Return On Assets of 8.42%. This is in the better half of the industry: CCL-B outperforms 75.00% of its industry peers.
CCL-B has a Return On Equity of 15.73%. This is amongst the best in the industry. CCL-B outperforms 87.50% of its industry peers.
CCL-B has a better Return On Invested Capital (9.53%) than 75.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CCL-B is in line with the industry average of 8.49%.
The last Return On Invested Capital (9.53%) for CCL-B is above the 3 year average (9.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROIC 9.53%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
CCL-B.CA Yearly ROA, ROE, ROICCCL-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

CCL-B has a better Profit Margin (11.61%) than 87.50% of its industry peers.
In the last couple of years the Profit Margin of CCL-B has grown nicely.
CCL-B has a better Operating Margin (14.83%) than 87.50% of its industry peers.
In the last couple of years the Operating Margin of CCL-B has remained more or less at the same level.
CCL-B's Gross Margin of 29.68% is in line compared to the rest of the industry. CCL-B outperforms 50.00% of its industry peers.
In the last couple of years the Gross Margin of CCL-B has remained more or less at the same level.
Industry RankSector Rank
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
CCL-B.CA Yearly Profit, Operating, Gross MarginsCCL-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CCL-B is creating some value.
The number of shares outstanding for CCL-B has been reduced compared to 1 year ago.
CCL-B has less shares outstanding than it did 5 years ago.
The debt/assets ratio for CCL-B has been reduced compared to a year ago.
CCL-B.CA Yearly Shares OutstandingCCL-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
CCL-B.CA Yearly Total Debt VS Total AssetsCCL-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

An Altman-Z score of 3.65 indicates that CCL-B is not in any danger for bankruptcy at the moment.
CCL-B's Altman-Z score of 3.65 is fine compared to the rest of the industry. CCL-B outperforms 62.50% of its industry peers.
The Debt to FCF ratio of CCL-B is 3.97, which is a good value as it means it would take CCL-B, 3.97 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 3.97, CCL-B is not doing good in the industry: 62.50% of the companies in the same industry are doing better.
CCL-B has a Debt/Equity ratio of 0.46. This is a healthy value indicating a solid balance between debt and equity.
CCL-B has a worse Debt to Equity ratio (0.46) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Altman-Z 3.65
ROIC/WACC1.38
WACC6.88%
CCL-B.CA Yearly LT Debt VS Equity VS FCFCCL-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

2.3 Liquidity

CCL-B has a Current Ratio of 2.13. This indicates that CCL-B is financially healthy and has no problem in meeting its short term obligations.
CCL-B has a Current ratio of 2.13. This is in the better half of the industry: CCL-B outperforms 62.50% of its industry peers.
A Quick Ratio of 1.55 indicates that CCL-B should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.55, CCL-B is doing good in the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 1.55
CCL-B.CA Yearly Current Assets VS Current LiabilitesCCL-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

5

3. Growth

3.1 Past

CCL-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.23%, which is quite impressive.
The Earnings Per Share has been growing by 10.99% on average over the past years. This is quite good.
Looking at the last year, CCL-B shows a quite strong growth in Revenue. The Revenue has grown by 9.80% in the last year.
The Revenue has been growing slightly by 6.37% on average over the past years.
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%

3.2 Future

Based on estimates for the next years, CCL-B will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.26% on average per year.
CCL-B is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.38% yearly.
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue Next Year5.18%
Revenue Next 2Y4.38%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCL-B.CA Yearly Revenue VS EstimatesCCL-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2B 4B 6B 8B
CCL-B.CA Yearly EPS VS EstimatesCCL-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

CCL-B is valuated correctly with a Price/Earnings ratio of 16.28.
CCL-B's Price/Earnings ratio is a bit more expensive when compared to the industry. CCL-B is more expensive than 75.00% of the companies in the same industry.
CCL-B's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.53.
With a Price/Forward Earnings ratio of 15.71, CCL-B is valued correctly.
Based on the Price/Forward Earnings ratio, CCL-B is valued a bit more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCL-B to the average of the S&P500 Index (22.27), we can say CCL-B is valued slightly cheaper.
Industry RankSector Rank
PE 16.28
Fwd PE 15.71
CCL-B.CA Price Earnings VS Forward Price EarningsCCL-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCL-B is valued a bit more expensive than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CCL-B is valued a bit more expensive than the industry average as 62.50% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 21.17
EV/EBITDA 10.07
CCL-B.CA Per share dataCCL-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

CCL-B has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.48
EPS Next 2Y2.88%
EPS Next 3Y8.26%

5

5. Dividend

5.1 Amount

CCL-B has a Yearly Dividend Yield of 1.64%.
Compared to an average industry Dividend Yield of 3.21, CCL-B has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.39, CCL-B is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.64%

5.2 History

On average, the dividend of CCL-B grows each year by 11.36%, which is quite nice.
CCL-B has been paying a dividend for at least 10 years, so it has a reliable track record.
CCL-B has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.36%
Div Incr Years23
Div Non Decr Years34
CCL-B.CA Yearly Dividends per shareCCL-B.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

24.59% of the earnings are spent on dividend by CCL-B. This is a low number and sustainable payout ratio.
CCL-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP24.59%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
CCL-B.CA Yearly Income VS Free CF VS DividendCCL-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
CCL-B.CA Dividend Payout.CCL-B.CA Dividend Payout, showing the Payout Ratio.CCL-B.CA Dividend Payout.PayoutRetained Earnings

CCL INDUSTRIES INC - CL B

TSX:CCL-B (6/6/2025, 7:00:00 PM)

78.15

+0.13 (+0.17%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-06 2025-08-06
Inst Owners40.46%
Inst Owner ChangeN/A
Ins Owners3.79%
Ins Owner ChangeN/A
Market Cap13.72B
Analysts82.11
Price Target93.13 (19.17%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.64%
Yearly Dividend1.16
Dividend Growth(5Y)11.36%
DP24.59%
Div Incr Years23
Div Non Decr Years34
Ex-Date06-13 2025-06-13 (0.32)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.41%
Min EPS beat(2)-1.39%
Max EPS beat(2)4.21%
EPS beat(4)2
Avg EPS beat(4)10.9%
Min EPS beat(4)-5.47%
Max EPS beat(4)46.26%
EPS beat(8)3
Avg EPS beat(8)2.39%
EPS beat(12)5
Avg EPS beat(12)1.9%
EPS beat(16)8
Avg EPS beat(16)2.43%
Revenue beat(2)0
Avg Revenue beat(2)-0.51%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)1.57%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.72%
Revenue beat(16)6
Avg Revenue beat(16)-1.07%
PT rev (1m)1.9%
PT rev (3m)0.55%
EPS NQ rev (1m)-1.85%
EPS NQ rev (3m)-4.44%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.54%
Revenue NQ rev (1m)-0.4%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.06%
Valuation
Industry RankSector Rank
PE 16.28
Fwd PE 15.71
P/S 1.86
P/FCF 21.17
P/OCF 13.12
P/B 2.51
P/tB 7.86
EV/EBITDA 10.07
EPS(TTM)4.8
EY6.14%
EPS(NY)4.97
Fwd EY6.37%
FCF(TTM)3.69
FCFY4.72%
OCF(TTM)5.95
OCFY7.62%
SpS42.12
BVpS31.09
TBVpS9.95
PEG (NY)N/A
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 8.42%
ROE 15.73%
ROCE 12.66%
ROIC 9.53%
ROICexc 10.53%
ROICexgc 19.98%
OM 14.83%
PM (TTM) 11.61%
GM 29.68%
FCFM 8.76%
ROA(3y)7.23%
ROA(5y)7.35%
ROE(3y)14.01%
ROE(5y)14.83%
ROIC(3y)9.32%
ROIC(5y)9.53%
ROICexc(3y)10.42%
ROICexc(5y)10.66%
ROICexgc(3y)20.67%
ROICexgc(5y)21.9%
ROCE(3y)12.39%
ROCE(5y)12.67%
ROICexcg growth 3Y-4.22%
ROICexcg growth 5Y-2.39%
ROICexc growth 3Y-1.48%
ROICexc growth 5Y-0.08%
OM growth 3Y0.47%
OM growth 5Y1.18%
PM growth 3Y3.65%
PM growth 5Y5.35%
GM growth 3Y2.04%
GM growth 5Y0.75%
F-Score8
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0.46
Debt/FCF 3.97
Debt/EBITDA 1.64
Cap/Depr 90.23%
Cap/Sales 5.37%
Interest Coverage 19.01
Cash Conversion 68.02%
Profit Quality 75.5%
Current Ratio 2.13
Quick Ratio 1.55
Altman-Z 3.65
F-Score8
WACC6.88%
ROIC/WACC1.38
Cap/Depr(3y)114.57%
Cap/Depr(5y)103.99%
Cap/Sales(3y)6.78%
Cap/Sales(5y)6.27%
Profit Quality(3y)87.06%
Profit Quality(5y)92.08%
High Growth Momentum
Growth
EPS 1Y (TTM)32.23%
EPS 3Y11.84%
EPS 5Y10.99%
EPS Q2Q%9.35%
EPS Next Y-0.82%
EPS Next 2Y2.88%
EPS Next 3Y8.26%
EPS Next 5YN/A
Revenue 1Y (TTM)9.8%
Revenue growth 3Y8.12%
Revenue growth 5Y6.37%
Sales Q2Q%8.63%
Revenue Next Year5.18%
Revenue Next 2Y4.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.05%
EBIT growth 3Y8.62%
EBIT growth 5Y7.62%
EBIT Next Year41.68%
EBIT Next 3Y15.95%
EBIT Next 5YN/A
FCF growth 1Y32.16%
FCF growth 3Y5.34%
FCF growth 5Y6.76%
OCF growth 1Y8.38%
OCF growth 3Y8.25%
OCF growth 5Y6.42%